JP5646851B2 - エレクトロポレーション支援ワクチン投与及び追加投与を用いた免疫応答の増強方法 - Google Patents

エレクトロポレーション支援ワクチン投与及び追加投与を用いた免疫応答の増強方法 Download PDF

Info

Publication number
JP5646851B2
JP5646851B2 JP2009537218A JP2009537218A JP5646851B2 JP 5646851 B2 JP5646851 B2 JP 5646851B2 JP 2009537218 A JP2009537218 A JP 2009537218A JP 2009537218 A JP2009537218 A JP 2009537218A JP 5646851 B2 JP5646851 B2 JP 5646851B2
Authority
JP
Japan
Prior art keywords
tissue
administration
muscle
skin
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2009537218A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010510218A5 (enExample
JP2010510218A (ja
Inventor
マティーセン，イアコブ
トルン チェッレ，エリザベート
トルン チェッレ，エリザベート
チェケン，ルネ
ラブッセイ，ディートマール
リン，フェン
Original Assignee
ジェネトロニクス，インコーポレイティド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ジェネトロニクス，インコーポレイティド filed Critical ジェネトロニクス，インコーポレイティド
Publication of JP2010510218A publication Critical patent/JP2010510218A/ja
Publication of JP2010510218A5 publication Critical patent/JP2010510218A5/ja
Application granted granted Critical
Publication of JP5646851B2 publication Critical patent/JP5646851B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2009537218A 2006-11-17 2007-11-16 エレクトロポレーション支援ワクチン投与及び追加投与を用いた免疫応答の増強方法 Active JP5646851B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85972406P 2006-11-17 2006-11-17
US60/859,724 2006-11-17
PCT/US2007/024051 WO2008063555A2 (en) 2006-11-17 2007-11-16 Methods of enhancing immune response using electroporation-assisted vaccination and boosting

Publications (3)

Publication Number Publication Date
JP2010510218A JP2010510218A (ja) 2010-04-02
JP2010510218A5 JP2010510218A5 (enExample) 2010-11-25
JP5646851B2 true JP5646851B2 (ja) 2014-12-24

Family

ID=39430332

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009537218A Active JP5646851B2 (ja) 2006-11-17 2007-11-16 エレクトロポレーション支援ワクチン投与及び追加投与を用いた免疫応答の増強方法

Country Status (8)

Country Link
US (1) US20100285040A1 (enExample)
EP (1) EP2091558B1 (enExample)
JP (1) JP5646851B2 (enExample)
KR (1) KR20090080941A (enExample)
CN (1) CN101522211A (enExample)
AU (1) AU2007322075B2 (enExample)
CA (1) CA2668649A1 (enExample)
WO (1) WO2008063555A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010148440A1 (en) 2009-06-24 2010-12-29 International Scientific Pty Ltd An apparatus and method of treatment utilizing a varying electromagnetic energisation profile
KR101723605B1 (ko) * 2014-10-21 2017-04-07 진원생명과학 주식회사 대상포진 예방 및 치료용 dna 백신 조성물 및 이를 이용한 vzv 항원에 대한 t세포 활성화 방법
US10233419B2 (en) 2016-06-30 2019-03-19 Zymergen Inc. Apparatuses and methods for electroporation

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US118956A (en) * 1871-09-12 Improvement in apparatus for the manufacture of extracts from hemlock and other
US5273525A (en) 1992-08-13 1993-12-28 Btx Inc. Injection and electroporation apparatus for drug and gene delivery
US6009345A (en) 1992-08-17 1999-12-28 Genetronics, Inc. Method and apparatus for a combination of electroporation and iontophoresis for the delivery of drugs and genes
US5439440A (en) 1993-04-01 1995-08-08 Genetronics, Inc. Electroporation system with voltage control feedback for clinical applications
US6261281B1 (en) 1997-04-03 2001-07-17 Electrofect As Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
US6110161A (en) 1997-04-03 2000-08-29 Electrofect As Method for introducing pharmaceutical drugs and nucleic acids into skeletal muscle
TW368420B (en) 1997-11-04 1999-09-01 Genetronics Inc Apparatus and method for transdermal molecular delivery by applying sufficient amplitude of electric field to induce migration of molecules through pores in the stratum corneum
US6972013B1 (en) 1998-07-13 2005-12-06 Genetronics, Inc. Enhanced delivery of naked DNA to skin by non-invasive in vivo electroporation
EP1148885A4 (en) * 1999-02-08 2002-05-08 Chiron Corp ELECTRICALLY INDUCED INCREASE IN IMMUNITY AND EFFECTIVENESS OF IN VIVO DNA VACCINES
US7171264B1 (en) * 1999-05-10 2007-01-30 Genetronics, Inc. Intradermal delivery of active agents by needle-free injection and electroporation
GB9922361D0 (en) * 1999-09-21 1999-11-24 Isis Innovation Generating an immune response to an antigen
ES2386884T3 (es) * 2000-11-01 2012-09-04 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Vectores de expresión capaces de inducir respuesta inmunomejorada y métodos para usarlos
CA2478614C (en) 2001-03-13 2013-01-15 University Of South Florida Electromanipulation device and method
WO2003072016A2 (en) * 2001-11-19 2003-09-04 Becton, Dickinson And Company Pharmaceutical compositions in particulate form
EP1474153A4 (en) * 2001-12-14 2005-12-14 Genetronics Inc PARTICLE-ASSISTED IMMUNIZATION METHODS BASED ON THE USE OF A PULSE ELECTRIC FIELD
US20060035853A1 (en) * 2004-01-07 2006-02-16 Biomedical Research Models, Inc. Methods for tailoring the immune response to an antigen or immunogen
EP1981581B1 (en) 2006-02-11 2016-04-13 Genetronics, Inc. Device for single-needle in vivo electroporation

Also Published As

Publication number Publication date
WO2008063555A3 (en) 2008-11-06
EP2091558B1 (en) 2018-04-04
EP2091558A2 (en) 2009-08-26
WO2008063555A2 (en) 2008-05-29
KR20090080941A (ko) 2009-07-27
US20100285040A1 (en) 2010-11-11
CA2668649A1 (en) 2008-05-29
AU2007322075A1 (en) 2008-05-29
AU2007322075B2 (en) 2013-07-25
JP2010510218A (ja) 2010-04-02
EP2091558A4 (en) 2012-07-04
CN101522211A (zh) 2009-09-02

Similar Documents

Publication Publication Date Title
JP7141063B2 (ja) 抗原およびアジュバントとしてのインターロイキン－２１を有するワクチン
CN1253220C (zh) 通过微管在真皮内输入疫苗和基因治疗剂
US20210353939A1 (en) Multiple Tissue Layer Electroporation Applicator and Device
CN104168912A (zh) 促进剂-dna组合疫苗
JP5646851B2 (ja) エレクトロポレーション支援ワクチン投与及び追加投与を用いた免疫応答の増強方法
JP2016514672A (ja) 抗原およびアジュバントとしてのインターロイキン−２３を有するワクチン
US11179458B2 (en) Immunogenicity of an optimized synthetic consensus DNA vaccine for porcine epidemic diarrhea virus
US20240009300A1 (en) Dna encoded nanoparticles and method of use thereof as a coronavirus disease 2019 (covid-19) vaccine
AU2013206520B2 (en) Methods of enhancing immune response using electroporation-assisted vaccination and boosting
HK1135848A (en) Methods of enhancing immune response using electroporation-assisted vaccination and boosting
US20250255954A1 (en) Stabilized spike protein and method of use thereof as a coronavirus disease 2019 (covid-19) vaccine
WO2025038695A1 (en) Modified h3 hemagglutinin antigens and methods of use thereof
WO2024182700A2 (en) Glycan modified sars-cov-2 glycoprotein nanoparticles and methods of use thereof
JP2000004715A (ja) 脊椎動物への遺伝子導入発現方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101005

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20101005

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130226

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130524

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130531

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130724

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140401

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140627

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140704

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140908

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20141007

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20141106

R150 Certificate of patent or registration of utility model

Ref document number: 5646851

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250